Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure

Journal of the American College of Cardiology

Volumn 26, Issue 7, 1995, Pages 1575-1580

  Gogia, Harinder ^a   Mehra, Anilkumar ^a   Parikh, Sunita ^a   Raman, Murli ^a   Ajit Uppal, Jasvir ^a   Johnson, Janet V ^a   Elkayam, Uri ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; HYDRALAZINE; NITRIC ACID DERIVATIVE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYPHYLAXIS;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYDRALAZINE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NITROGLYCERIN; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; VASODILATOR AGENTS;

EID: 0028784929     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00368-1     Document Type: Article

References (35)

1. Use of nitrates in ischemic heart disease
2. Nitrates in heart failure
3. Incidence of early tolerance to hemodynamic effects of continuous nitroglycerin infusion in patients with coronary artery disease and heart failure
4. Solving the mystery of nitrate tolerance: a new scent on the trail?
5. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine
6. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease
7. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure
8. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure
9. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study (V-HeFT)
10. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
11. Cardiac output by thermodilution technique: effect of injectate volume and temperature on accuracy and reproducibility in the critically ill patient
12. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy on right heart catheterization in patients with chronic heart failure
13. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure
14. Prevention and reversal of nitrate tolerance in patients with congestive heart failure
15. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure
16. Mechanisms of nitrate action and vascular tolerance
17. Methionine restores the venodilative response to nitroglycerin after the development of tolerance
18. Prevention of nitrate tolerance with angiotensin converting enzyme inhibitors
19. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic heart failure already treated with captopril
20. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure
21. Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin
22. Diuretic therapy improves exercise capacity in patients with angina but has no effect on nitrate tolerance
23. Early tolerance to hemodynamic effects of high-dose transdermal nitroglycerin in responders with severe chronic heart failure
24. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic heart failure
25. Interaction between hydralazine and nitroglycerin in vascular smooth muscle
26. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination
27. Peripheral vascular effects of nitroglycerin in a conscious rat model of heart failure
28. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure
29. Dose requirements of hydralazine in patients with severe chronic congestive heart failure
30. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure
31. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects
32. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure
33. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure
34. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure
35. Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure